SEARCH

SEARCH BY CITATION

References

  • 1
    Lerner C.G., Beutel B.A. (2002) Antibacterial drug discovery in the post-genomics era. Curr Drug Targets Infect Disord;2: 109119.
  • 2
    Gu Y.G., Florjancic A.S., Clark R.F., Zhang T., Cooper C.S., Anderson D.D., Lerner C.G., McCall J.O., Cai Y., Black-Schaefer C.L., Stamper G.F., Hajduk P.J., Beutel B.A. (2004) Structure-activity relationships of novel potent MurF inhibitors. Bioorg Med Chem Lett;14: 267270.
  • 3
    Anderson M.S., Eveland S.S., Onishi H.R., Pompliano D.L. (1996) Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion. Biochemistry;35: 1626416269.
  • 4
    El Zoeiby A., Sanschagrin F., Levesque R.C. (2003) Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol;47: 112.
  • 5
    Miller D.J., Hammond S.M., Anderluzzi D., Bugg T.D.H. (1998) Aminoalkylphosphinate inhibitors of D-Ala-D-Ala adding enzyme. J Chem Soc Perkin Trans;1: 131142.
  • 6
    Longenecker K.L., Stamper G.F., Hajduck P.J., Fry E.H., Jakob C.G., Harlan J.E., Edalji R., Bartley D.M., Walter K.A., Solomon L.R., Holzman T.F., Gu Y.G., Lerner C.G., Beutel B.A., Stoll V.S. (2005) Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure. Protein Science 2005;14: 30393047.
  • 7
    Yan Y., Munshi S., Leiting B., Anderson M.S., Chrzas J., Chen Z. (2000) Crystal structure of Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme (MurF) at 2.3 A resolution. J Mol Biol;304: 435445.
  • 8
    Muchmore S.W., Hajduk P.J. (2003) Crystallography, NMR and virtual screening: integrated tools for drug discovery. Curr Opin Drug Discov Dev;6: 544549.
  • 9
    Davis A.M., Teague S.J., Kleywegt G.J. (2003) Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. Angew Chem Int Ed Engl;42: 27182736.
  • 10
    Blundell T.L., Patel S. (2004) High-throughput X-ray crystallography for drug discovery. Curr Opin Pharmacol;4: 490496.
  • 11
    Hajduk P.J., Mack J.C., Olejniczak E.T., Park C., Dandliker P.J., Beutel B.A. (2004) SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. J Am Chem Soc;126: 23902398.
  • 12
    Hajduk P.J., Burns D.J. (2002) Integration of NMR and high-throughput screening. Comb Chem High Throughput Screen;5: 613621.
  • 13
    Hajduk P.J., Bures M., Praestgaard J., Fesik S.W. (2000) Privileged molecules for protein binding identified from NMR-based screening. J Med Chem;43: 34433447.
  • 14
    Otwinowski Z., Minor W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol;276: 307326.
  • 15
    Hajduk P.J., Augeri D.J., Mack J., Mendoza R., Yang J., Betz S.F., Fesik S.W. (2000) NMR-based screening of proteins containing 13C-labeled methyl groups. J Am Chem Soc;122: 78987904.
  • 16
    Piotto M., Saudek V., Sklenar V. (1992) Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR;2: 661665.
  • 17
    Hajduk P.J., Gerfin T., Boehlen J.M., Haberli M., Marek D., Fesik S.W. (1999) High-throughput nuclear magnetic resonance-based screening. J Med Chem;42: 23152317.
  • 18
    Seals J.R., McDonald J.M., Bruns D., Jarett L. (1978) A sensitive and precise isotopic assay of ATPase activity. Anal Biochem;90: 785795.
  • 19
    Skarzynski T., Mistry A., Wonacott A., Hutchinson S.E., Kelly V.A., Duncan K. (1996) Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure;4: 14651474.
  • 20
    Benson T.E., Walsh C.T., Hogle J.M. (1996) The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls. Structure;4: 4754.
  • 21
    Mol C.D., Brooun A., Dougan D.R., Hilgers M.T., Tari L.W., Wijnands R.A., Knuth M.W., McRee D.E., Swanson R.V. (2003) Crystal structures of active fully assembled substrate- and product-bound complexes of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) from Haemophilus influenzae. J Bacteriol;185: 41524162.
  • 22
    Bertrand J.A., Auger G., Martin L., Fanchon E., Blanot D., Le Beller D., van Heijenoort J., Dideberg O. (1999) Determination of the MurD mechanism through crystallographic analysis of enzyme complexes. J Mol Biol;289: 579590.
  • 23
    Gordon E., Flouret B., Chantalat L., van Heijenoort J., Mengin-Lecreulx D., Dideberg O. (2001) Crystal structure of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-diaminopimelate ligase from Escherichia coli. J Biol Chem;276: 1099911006.
  • 24
    Baum E.Z., Montenegro D.A., Licata L., Turchi I., Webb G.C., Foleno B.D., Bush K. (2001) Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme. Antimicrob Agents Chemother;45: 31823188.
  • 25
    Bronson J.J., DenBleyker K.L., Falk P.J., Mate R.A., Ho H.T., Pucci M.J., Snyder L.B. (2003) Discovery of the first antibacterial small molecule inhibitors of MurB. Bioorg Med Chem Lett;13: 873875.
  • 26
    Francisco G.D., Li Z., Albright J.D., Eudy N.H., Katz A.H., Petersen P.J., Labthavikul P., Singh G., Yang Y., Rasmussen B.A., Lin Y.I., Mansour T.S. (2004) Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis. Bioorg Med Chem Lett;14: 235238.